CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid in Capital	Retained Earnings (Accumulated Loss)	Retained Earnings (Accumulated Loss) Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Beginning balance at Dec. 31, 2019	$ (2,108)	$ (6)	$ 1	$ 1,208	$ (2,954)	$ (6)	$ (175)	$ (292)	$ 104
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds in connection with settlement of stock options and RSUs	4			4
Stock-based compensation	60			56					4
Net income (loss)	(548)				(569)				21
Other comprehensive loss	74							74
Ending balance at Dec. 31, 2020	(2,524)		1	1,268	(3,529)		(175)	(218)	129
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds in connection with settlement of stock options and RSUs	(20)			(20)
Stock-based compensation	91			89					2
Net income (loss)	390				371				19
Other comprehensive loss	(43)							(43)
Ending balance at Dec. 31, 2021	(2,106)		1	1,337	(3,158)		(175)	(261)	150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Settlement of liability awards	43			43
Net proceeds in connection with settlement of stock options and RSUs	(35)			(35)
Purchase of treasury stock	405						(405)
Purchase of SciPlay Class A common stock	(37)			(35)					(2)
Stock-based compensation	61			60					1
Net income (loss)	3,697				3,675				22
Other comprehensive loss	(57)							(57)
Ending balance at Dec. 31, 2022	$ 1,161		$ 1	$ 1,370	$ 517		$ (580)	$ (318)	$ 171